REVB
Revelation Biosciences Inc
NASDAQ: REVB · HEALTHCARE · BIOTECHNOLOGY
$1.12
-0.88% today
Updated 2026-05-01
Market cap
$4.32M
P/E ratio
—
P/S ratio
2.88x
EPS (TTM)
$-23.95
Dividend yield
—
52W range
$1 – $40
Volume
0.1M
Revelation Biosciences Inc (REVB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-131.40%
ROA
-62.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2014 | $21.07M | $4.50M | 100.00% | 35.33% | 21.38% |
| 2015 | $27.66M | $6.20M | 100.00% | 37.15% | 22.42% |
| 2016 | $48.81M | $8.78M | 92.69% | 38.43% | 17.98% |
| 2017 | $74.00M | $16.27M | 95.71% | 44.17% | 21.99% |
| 2018 | $85.11M | $27.63M | 95.15% | 45.70% | 32.46% |
| 2019 | $95.81M | $-3638.00 | 94.88% | -0.00% | -0.00% |
| 2020 | — | $-136408.00 | — | — | — |
| 2021 | $0.00 | $-11.99M | — | — | — |
| 2022 | $0.00 | $-10.83M | — | — | — |
| 2023 | $0.00 | $-120254.00 | — | — | — |
| 2024 | $0.00 | $-15.04M | — | — | — |
| 2025 | $0.00 | $-8.91M | — | — | — |